MB-CART2019.1

· Miltenyi Biomedicine GmbH

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for MB-CART2019.1, covering 2025-05-28 to 2026-01-08. Get the full timeline:

Most recent: Clinical Trial Update: DALY II Japan/MB-CART2019.1 for DLBCL [Phase 2]